LEAN Cell & Gene Summit Boston
For years, CGT developers have impressed investors with potentially curative drug products. But they’ve also carried a serious burden: manufacturing platforms too inefficient to cost-effectively serve their addressable patient populations.
Now, as the field faces what is likely its most challenging funding environment yet, clinical promise alone is no longer enough. Investors are demanding that CGT products be manufactured with the efficiency and scalability required to meet real-world demand, and survival in this market depends on building highly efficient, fully scalable manufacturing operations.
The good news? Other industries have already paved the way. LEAN manufacturing principles offer a commonsense, cost-effective roadmap to doing more with less, without compromising on quality or innovation.
Don't fall behind. Take a step toward becoming indispensable to your organization by attending our no-cost* LEAN Cell & Gene Boston Summit on Monday, September 22, conveniently planned just one day before the CAR-TCR Summit.
What you’ll gain from attending:
- Low risk, high reward strategies to reduce wate and costs: learn how to spot inefficiencies in your operations and apply LEAN solutions that accelerate timelines and cut unnecessary spending
- A clear framework for continuous improvement and stable operations: discover how to embed LEAN thinking into your team’s mindset to drive sustained innovation, accountability, and operational excellence
- Smarter, scalable manufacturing approaches: explore how to design flexible, modular processes that support seamless scaling from early development through to commercialization
View the full agenda here: https://ter.li/dfdd1m
*Visit the website for full T&Cs.
